IRIS
AVOLIO, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.554
EU - Europa 3.810
AS - Asia 2.673
Continente sconosciuto - Info sul continente non disponibili 1.154
SA - Sud America 531
AF - Africa 60
OC - Oceania 11
Totale 13.793
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.415
SG - Singapore 1.032
IE - Irlanda 889
CN - Cina 800
RU - Federazione Russa 569
IT - Italia 491
UA - Ucraina 486
BR - Brasile 429
SE - Svezia 389
HK - Hong Kong 289
DE - Germania 272
FR - Francia 257
VN - Vietnam 176
FI - Finlandia 155
GB - Regno Unito 112
IN - India 98
BD - Bangladesh 69
TR - Turchia 68
CA - Canada 61
AR - Argentina 40
BE - Belgio 39
NL - Olanda 29
AT - Austria 25
ID - Indonesia 24
MX - Messico 22
ES - Italia 20
PL - Polonia 20
CR - Costa Rica 17
ZA - Sudafrica 17
EC - Ecuador 16
IQ - Iraq 16
EU - Europa 15
VE - Venezuela 15
JP - Giappone 14
IR - Iran 13
PK - Pakistan 12
CL - Cile 10
CZ - Repubblica Ceca 10
AU - Australia 8
PT - Portogallo 8
SC - Seychelles 8
CO - Colombia 7
TN - Tunisia 7
GT - Guatemala 6
JM - Giamaica 6
JO - Giordania 6
LT - Lituania 6
MA - Marocco 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
HN - Honduras 5
HU - Ungheria 5
PH - Filippine 5
PY - Paraguay 5
SA - Arabia Saudita 5
SV - El Salvador 5
XK - ???statistics.table.value.countryCode.XK??? 5
BO - Bolivia 4
DZ - Algeria 4
MY - Malesia 4
PR - Porto Rico 4
CH - Svizzera 3
EE - Estonia 3
EG - Egitto 3
HR - Croazia 3
NP - Nepal 3
PE - Perù 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GP - Guadalupe 2
GR - Grecia 2
KE - Kenya 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MN - Mongolia 2
MU - Mauritius 2
NI - Nicaragua 2
PS - Palestinian Territory 2
UY - Uruguay 2
VC - Saint Vincent e Grenadine 2
AD - Andorra 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
Totale 12.640
Salva come PNG Salva come JPEG
Città #
San Jose 1.024
Dublin 888
Chandler 403
Singapore 397
Ashburn 370
Jacksonville 331
Nyköping 286
Hong Kong 284
Dearborn 269
Beijing 224
Dallas 175
Council Bluffs 164
Santa Clara 160
Nanjing 145
Columbus 126
Lauterbourg 111
Princeton 102
Wilmington 91
Moscow 77
New York 77
The Dalles 77
Munich 76
Helsinki 73
Nanchang 65
Woodbridge 60
Ann Arbor 59
Los Angeles 53
Ho Chi Minh City 52
San Mateo 51
Hanoi 40
Brussels 39
Boardman 37
Des Moines 33
Jiaxing 33
São Paulo 33
Turku 33
Shenyang 30
Foggia 29
Milan 29
Seattle 28
Nuremberg 26
Frankfurt am Main 25
Naples 25
Tianjin 25
Rome 24
Chicago 22
Bari 21
Cedar Knolls 21
Changsha 21
Hebei 21
Phoenix 20
Kunming 19
Leland 17
San Francisco 16
Atlanta 15
Guangzhou 15
San José 15
Warsaw 15
Zhengzhou 15
Agrolândia 14
Hangzhou 14
London 14
Rio de Janeiro 14
Orem 13
Tokyo 13
Brasília 12
San Severo 12
Brooklyn 11
Falkenstein 11
Hilden 11
Montreal 11
Ningbo 11
Norwalk 11
Redwood City 11
Taizhou 11
Boston 10
Curitiba 10
Hudson 10
Jinan 10
Belo Horizonte 9
Bologna 9
Buffalo 9
Kocaeli 9
North Bergen 9
Pimonte 9
Toronto 9
Assago 8
Auburn Hills 8
Fortaleza 8
Haddonfield 8
Johannesburg 8
Lanzhou 8
Ottawa 8
Quito 8
Baghdad 7
Bắc Ninh 7
Falls Church 7
Haiphong 7
Jakarta 7
Mexico City 7
Totale 7.415
Salva come PNG Salva come JPEG
Nome #
Do patients and referral centers characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 212
Serum Soluble Intercellular Adhesion Molecule-1 in MS: relation to clinical and Gd-MRI activity, and to rIFNβ-1b treatment. 167
Serial immunoprecipitation assays for interferon-(IFN)-beta antibodies in multiple sclerosis patients. 155
Comparison of Clinical and demographic features between affected pairs of Italian Multiple Sclerosis Multiplex families; relation to Tumor Necrosis Factor genomic polymorphisms. 155
Defining the electroclinical phenotype and outcome of PCDH19‐related epilepsy: A multicenter study 154
Analisi fenotipica di linfociti T di pazienti con Sclerosi multipla (SM) nel sangue periferico ed in coltura con e senza aggiunta di mitogeni 152
Anti-Inflammatory and Anti-Oxidant Effect of Dimethyl Fumarate in Cystic Fibrosis Bronchial Epithelial Cells 151
Changes of serum ICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS. 149
Analisi liquorale per la diagnosi ed il follow-up di malattie infiammatorie del SNC. 148
The epilepsy phenotype in adult patients with intellectual disability and pathogenic copy number variants 146
Intravenous lacosamide in seizure emergencies: Observations from a hospitalized in-patient adult population. 145
Adhesion molecules and matrix metalloproteinases in MS: effects induced by Interferon beta. 144
Consensus recommendations of the Italian Association for Neuroimmunology for immunochemical cerebrospinal fluid examination. 143
Espressione di LFA-1 su linfociti memoria CD4+CD45RO+ si sangue periferico nella Sclerosi Multipla remittente: effetti indotti dall’ IFN b-1a. 142
Age-Related Disability in Multiple Sclerosis. 140
CSF and serum soluble adhesion molecules in Multiple Sclerosis 140
Between-laboratory variability in oligoclonal IgG band numbering. 137
Italian cohort of Lafora disease: Clinical features, disease evolution, and genotype-phenotype correlations 137
Design of a European multicenter study dedicated to the evaluation of the EDMUS system: EVALUED. 136
Usefulness of a standardized method for collecting anamnestic data in multiple sclerosis (MS). 135
European Validation of a Standardized Clinical Description of Multiple Sclerosis. 134
Disease duration, relapse rate and clinical course in Multiple Sclerosis. Relation to IgG production within the blood-brain barrier. 134
T regulatory cells are markers of disease activity in multiple sclerosis patients. 133
Tremor, sensory-motor polyneuropathy and cerebral gliosis in klinefelter's syndrome 132
Differential regulation of membrane bound and soluble ICAM 1 in human endothelium and blood mononuclear cells: effects of interferon beta-1a. 132
L’ esame del liquor (CSF) nella diagnosi di Sclerosi Multipla (SM) 130
Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients. 130
New Insights Into Immune Cell-Derived Extracellular Vesicles in Multiple Sclerosis. 130
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in Multiple Sclerosis: relationships with different MRI measures of disease activity during IFN-beta-1a treatment. 129
Counting of peripheral extracellular vesicles in Multiple Sclerosis patients by an improved nanoplasmonic assay and dynamic light scattering 129
Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events. 128
Soluble Intercellular Adhesion Molecule-1 in serum and cerebrospinal fluid (CSF) of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA Magnetic Resonance Imaging enhancement and CSF findings. 128
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis 126
Prognostic indicators in pediatric clinically isolated syndrome. 126
Intrathecal IgG synthesis and clinical course in Multiple Sclerosis 125
Wernicke's encephalopathy following reduced food intake due to depressive disorders. 125
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 125
Effects of rIFNbeta-1b on serum circulating ICAM-1 in relapsing remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cells. 124
Post-marketing of disease modifying drugs in multiple sclerosis: An exploratory analysis of gender effect in interferon beta treatment. 123
Soluble Intercellular adhesion molecule-1 (sICAM-1) in serum and cerebrospinal fluid of demyelinating diseases of the central and the peripheral nervous system. 123
Late-onset Leber hereditary optic neuropathy mimiking Susac’s syndrome 123
Serum MMP-2 and MMP-9 are elevated in different Multiple Sclerosis subtypes. 122
Immune and central nervous system-related miRNAs expression profiling in monocytes of multiple sclerosis patients. 121
MicroRNAs 181a and 125a are highly expressed in naïve RRMS: a pilot case-control study 120
Interferon beta in relapsing / remitting multiple sclerosis: an independent postmarketing study in southern Italy. 120
First-aid management of tonic-clonic seizures among healthcare personnel: A survey by the Apulian section of the Italian League Against Epilepsy 119
LFA-1 expressing CD4+CD45RO+ peripheral blood T-lymphocytes in RR MS: effects induced by rIFNbeta-1a. 118
Epstein–Barr virus (EBV) and multiple sclerosis association: EBV has a primary or secondary role? 118
Quantitation of intrathecal measles virus IgG antibody synthesis rate: Subacute sclerosing panencephalitis and multiple sclerosis. 118
Soluble Intercellular Adhesion Molecule-1 (sICAM-1) nel siero e liquor di pazienti con sclerosi multipla remittente clinicamente attiva: correlazioni con lesioni RMI che assumono gadolinio e con parametri liquorali 118
Il ruolo dell’ esame del liquor 116
Effect of fingolimod action on the release of monocyte-derived microvesicles in multiple sclerosis patients. 116
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 116
Krebs cycle derivatives, dimethyl fumarate and itaconate, control metabolic reprogramming in inflammatory human microglia cell line 115
Glatiramer Acetate in Multiple Sclerosis: a review 115
An Italian multicentre study of perampanel in progressive myoclonus epilepsies 115
Glatiramer Acetate induces pro-apoptotic mechanisms involving Bcl-2, Bax and Cyt-c in peripheral lymphocytes from Multiple Sclerosis patients. 112
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 112
Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis. 111
Usefulness of a standardised collection of disease events for clinical studies in Multiple Sclerosis. 111
P2X7 purinergic receptor on monocytes of patients with Multiple Sclerosis: effects of Glatiramer Acetate immune modulation 110
Pharmacological treatment of depression in Alzheimer's disease: A challenging task 110
Faciobrachial dystonic seizures expressed as epileptic spasms, followed by focal seizures in anti-LGI1 encephalitis: a video-polygraphic study. 108
Brivaracetam in Absence Status Epilepticus 107
Perceptive and Subjective Evaluation of Speech Disorders in Parkinson's Disease 107
Effetti antinfiammatori dell’ Interferone beta-1b ricombinante nella Sclerosi Multipla: studio longitudinale dei livelli sierici della forma solubile di Intercellular Adhesion Molecule-1 (sICAM-1) e dei subsets linfocitari 106
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 105
IMMUNOSENESCENCE AND MULTIPLE SCLEROSIS: PROGNOSTIC AND THERAPEUTIC IMPLICATIONS 105
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives 105
Real world comparison of teriflunomide and dimethyl fumarate in naïve relapsing multiple sclerosis patients: Evidence from the Italian MS register 103
Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implications 102
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases 102
Comparing STRATIFY JCV™ DxSelect™ and IMMUNOWELL™ JCV IgG Tests in RRMS to Assess PML Risk 101
How the cognitive reserve interacts with β-amyloid deposition in mitigating FDG metabolism: An observational study. 101
Association of Loneliness with Functional and Cognitive Status in Minor and Major Neurocognitive Disorders 100
Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Use in Central Nervous System Demyelinating Disorders 100
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register. 99
The effect of quarantine due to Covid-19 pandemic on seizure frequency in 102 adult people with epilepsy from Apulia and Basilicata regions, Southern Italy 99
The Italian multiple sclerosis register 98
Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease 98
Fisiopatologia della risposta immunitaria nel compartimento liquorale. XXXVII Congress of the Italian Neurological Society, Bari 14-18 October 2006. 97
IgG and IgM antibodies to the refolded MOG(1-125) extracellular domain in humans. 95
Fluctuations of MS births and UV-light exposure. 95
Weight loss and decubitus duodenal ulcer in Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion. 94
Molecular Characterization of Peripheral Extracellular Vesicles in Clinically Isolated Syndrome: Preliminary Suggestions from a Pilot Study 94
Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis. 94
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 90
Stopping Interferon Beta 1b Does Not Influence the Risk of Disability Accrual in Non-Active SPMS: Results from an Italian Real-World Study 89
Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer's disease 88
Evaluating Cognitive Outcomes in Multiple Sclerosis: Real-World Impact of Ozanimod on Processing Speed Using BICAMS 86
An Association of Framingham Risk Score with Patient Determined Disease Steps in a Cohort of Relapsing-Remitting Multiple Sclerosis Patients: An Italian Real-World Monocentric Experience 86
Multiple Sclerosis Treatments Affect Monocyte-Derived Microvesicle Production. 83
Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression (Q1 WoS) 83
Unraveling the inflammation-degeneration tangle in early MS: preliminary insights from ferritin, neurogranin, TREM2, and retinal ganglion cell layer 82
Treatment with metformin in twelve patients with Lafora disease 82
Guillain-Barré syndrome as only manifestation of COVID-19 infection 82
First-line therapies in Late Onset Multiple Sclerosis: an Italian registry study 82
Real-life impact of early interferonβ therapy in relapsing multiple sclerosis 81
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries 79
Lactobacilli Cell-Free Supernatants Modulate Inflammation and Oxidative Stress in Human Microglia via NRF2-SOD1 Signaling 76
Totale 11.694
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.267
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.267
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022442 0 0 0 15 41 10 19 30 66 56 40 165
2022/20232.491 198 129 105 157 119 191 18 144 1.049 117 186 78
2023/2024389 65 55 23 24 43 69 32 17 4 8 18 31
2024/20252.252 64 37 55 54 57 247 194 174 483 156 247 484
2025/20264.111 222 446 395 524 223 191 749 376 350 249 131 255
2026/20271.340 130 324 391 495 0 0 0 0 0 0 0 0
Totale 13.793